{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:15:21Z","timestamp":1767374121003,"version":"3.40.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental and Molecular Pathology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.yexmp.2016.12.006","type":"journal-article","created":{"date-parts":[[2016,12,11]],"date-time":"2016-12-11T10:01:16Z","timestamp":1481450476000},"page":"25-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis"],"prefix":"10.1016","volume":"102","author":[{"given":"Heidi V.N.","family":"K\u00fcsters-Vandevelde","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vibeke","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Van Maerken","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Boterberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolph","family":"Pfundt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Creytens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Van den Broecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trudi C.","family":"Machielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8763-8864","authenticated-orcid":false,"given":"Christian","family":"Koelsche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"von Deimling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benno","family":"K\u00fcsters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia J.T.A.","family":"Groenen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pieter","family":"Wesseling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willeke A.M.","family":"Blokx","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexmp.2016.12.006_bb0005","series-title":"WHO Classification of Tumours of the Central Nervous System","first-page":"181","article-title":"Melanocytic lesions","author":"Brat","year":"2007"},{"key":"10.1016\/j.yexmp.2016.12.006_bb0010","series-title":"WHO Classification of Tumours of the Central Nervous System","first-page":"266","article-title":"Melanocytic tumors","author":"Brat","year":"2016"},{"key":"10.1016\/j.yexmp.2016.12.006_bb0015","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1025628802228","article-title":"Meningeal melanocytoma: an aggressive course for a benign tumor","volume":"64","author":"Bydon","year":"2003","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0020","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/1078-0432.CCR-10-2076","article-title":"Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification","volume":"16","author":"Damato","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0025","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00401-015-1423-2","article-title":"Primary leptomeningeal melanoma is part of the BAP1-related cancer syndrome","volume":"129","author":"de la Fouchardiere","year":"2015","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0030","doi-asserted-by":"crossref","first-page":"5133","DOI":"10.1158\/1078-0432.CCR-10-1497","article-title":"Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers","volume":"16","author":"Gaujoux","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-7819-9-6","article-title":"Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene","volume":"9","author":"Griniatsos","year":"2011","journal-title":"World J. Surg. Oncol."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0040","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1126\/science.1194472","article-title":"Frequent mutation of BAP1 in metastasizing uveal melanomas","volume":"330","author":"Harbour","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.yexmp.2016.12.006_bb0045","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ng.2523","article-title":"Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma","volume":"45","author":"Harbour","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0050","doi-asserted-by":"crossref","first-page":"9852","DOI":"10.1158\/0008-5472.CAN-06-1796","article-title":"A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma","volume":"66","author":"Jenkins","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0055","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/bpa.12228","article-title":"Melanotic tumors of the nervous system are characterized by distinct mutational, chromosomal and epigenomic profiles","volume":"25","author":"Koelsche","year":"2014","journal-title":"Brain Pathol."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0060","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1750-3639.2002.tb00472.x","article-title":"June 2002: 57-year-old male with leptomeningeal and liver tumors","volume":"12","author":"Koenigsmann","year":"2002","journal-title":"Brain Pathol."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0065","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s12253-014-9841-3","article-title":"Mutations in g protein encoding genes and chromosomal alterations in primary leptomeningeal melanocytic neoplasms","volume":"21","author":"Kusters-Vandevelde","year":"2015","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40478-016-0272-0","article-title":"SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas","volume":"4","author":"Kusters-Vandevelde","year":"2016","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0075","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1212\/WNL.0b013e3181e1cf3a","article-title":"All the 1p19q codeleted gliomas are mutated on IDH1 or IDH2","volume":"74","author":"Labussiere","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.yexmp.2016.12.006_bb0080","doi-asserted-by":"crossref","first-page":"3687","DOI":"10.1002\/cncr.28282","article-title":"Clinical activity of ipilimumab for metastatic uveal melanoma: a retrospective review of the Dana-Farber Cancer Institute, Massachusetts General Hospital, Memorial Sloan-Kettering Cancer Center, and University Hospital of Lausanne experience","volume":"119","author":"Luke","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.yexmp.2016.12.006_bb0085","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/ng.2674","article-title":"Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3","volume":"45","author":"Martin","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0090","doi-asserted-by":"crossref","first-page":"E867","DOI":"10.1227\/01.NEU.0000372919.96651.34","article-title":"Malignant transformation of intramedullary melanocytoma: case report","volume":"67","author":"Perrini","year":"2010","journal-title":"Neurosurgery"},{"key":"10.1016\/j.yexmp.2016.12.006_bb0095","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11060-014-1400-y","article-title":"Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases","volume":"118","author":"Queirolo","year":"2014","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0100","first-page":"225","article-title":"Therapeutic options for meningeal melanocytoma. Case report","volume":"95","author":"Rades","year":"2001","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0105","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2012-2198","article-title":"Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma","volume":"98","author":"Raymond","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0110","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2012.48.0988","article-title":"Adrenocortical carcinoma is a lynch syndrome-associated cancer","volume":"31","author":"Raymond","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0115","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1200\/JCO.2014.56.2736","article-title":"Pooled analysis of long-term survival data from phase II and phase III trials of ipilimumab in unresectable or metastatic melanoma","volume":"33","author":"Schadendorf","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0120","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11060-015-2052-2","article-title":"Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system","volume":"127","author":"van de Nes","year":"2016","journal-title":"J. Neuro-Oncol."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0125","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexmp.2016.12.006_bb0130","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3171\/spi.2007.6.5.451","article-title":"Malignant transformation of spinal meningeal melanocytoma. Case report and review of the literature","volume":"6","author":"Wang","year":"2007","journal-title":"J. Neurosurg. Spine"},{"key":"10.1016\/j.yexmp.2016.12.006_bb0135","doi-asserted-by":"crossref","first-page":"e0118564","DOI":"10.1371\/journal.pone.0118564","article-title":"Phase II DeCOG-study of ipilimumab in pretreated and treatment-naive patients with metastatic uveal melanoma","volume":"10","author":"Zimmer","year":"2015","journal-title":"PLoS One"}],"container-title":["Experimental and Molecular Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480016300661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014480016300661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T21:54:35Z","timestamp":1658008475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014480016300661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0014480016300661"],"URL":"https:\/\/doi.org\/10.1016\/j.yexmp.2016.12.006","relation":{},"ISSN":["0014-4800"],"issn-type":[{"type":"print","value":"0014-4800"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Copy number variation analysis and methylome profiling of a GNAQ-mutant primary meningeal melanocytic tumor and its liver metastasis","name":"articletitle","label":"Article Title"},{"value":"Experimental and Molecular Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexmp.2016.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}